[1] [1] Hassan M, Latif N, Yacoub M. Adipose tissue: friend or foe?[J]. Nat Rev Cardiol, 2012, 9(12): 689-702.

[2] [2] Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ[J]. Mol Cell Endocrinol, 2010, 316(2): 129-139.

[3] [3] Rosen CJ, Horowitz MC. Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss[J]. Nat Rev Endocrinol, 2023, 19(11): 626-638.

[4] [4] de Paula FJA, Rosen CJ. Marrow adipocytes: origin, structure, and function[J]. Annu Rev Physiol, 2020, 82: 461-484.

[5] [5] Hirakawa H, Gao L, Tavakol DN, et al. Cellular plasticity of the bone marrow niche promotes hematopoietic stem cell regeneration[J]. Nat Genet, 2023, 55(11): 1941-1952.

[6] [6] Suchacki KJ, Tavares AAS, Mattiucci D, et al. Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis[J]. Nat Commun, 2020, 11(1): 3097.

[7] [7] Cawthorn WP, Scheller EL, Learman BS, et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction[J]. Cell Metab, 2014, 20(2): 368-375.

[8] [8] Scheller EL, Troiano N, Vanhoutan JN, et al. Use of osmium tetroxide staining with microcomputerized tomography to visualize and quantify bone marrow adipose tissue in vivo[J]. Methods Enzymol, 2014, 537: 123-139.

[9] [9] Cawthorn WP, Scheller EL, Parlee SD, et al. Expansion of bone marrow adipose tissue during caloric restriction is associated with increased circulating glucocorticoids and not with hypoleptinemia[J]. Endocrinology, 2016, 157(2): 508-521.

[10] [10] Xu W, Mesa-Eguiagaray I, Morris DM, et al. Deep learning and genome-wide association meta-analyses of bone marrow adiposity in the UK Biobank[J]. Nat Commun, 2025, 16(1): 99.

[11] [11] Craft CS, Scheller EL. Evolution of the marrow adipose tissue microenvironment[J]. Calcif Tissue Int, 2017, 100(5): 461-475.

[14] [14] Adler BJ, Kaushansky K, Rubin CT. Obesity-driven disruption of haematopoiesis and the bone marrow niche[J]. Nat Rev Endocrinol, 2014, 10(12): 737-748.

[16] [16] Scheller EL, Cawthorn WP, Burr AA, et al. Marrow adipose tissue: trimming the fat[J]. Trends Endocrinol Metab, 2016, 27(6): 392-403.

[17] [17] Li Z, Bowers E, Zhu J, et al. Lipolysis of bone marrow adipocytes is required to fuel bone and the marrow niche during energy deficits[J]. Elife, 2022, 11: e78496.

[18] [18] Robles H, Park S, Joens MS, et al. Characterization of the bone marrow adipocyte niche with three-dimensional electron microscopy[J]. Bone, 2019, 118: 89-98.

[19] [19] McGrath C, Sankaran JS, Misaghian-Xanthos N, et al. Exercise degrades bone in caloric restriction, despite suppression of marrow adipose tissue (MAT)[J]. J Bone Miner Res, 2019, 35(1): 106-115.

[20] [20] Tencerova M, Ferencakova M, Kassem M. Bone marrow adipose tissue: role in bone remodeling and energy metabolism[J]. Best Pract Res Clin Endocrinol Metab, 2021, 35(4): 101545.

[21] [21] Yeung DKW, Griffith JF, Antonio GE, et al. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study[J]. J Magn Reson Imaging, 2005, 22(2): 279-285.

[22] [22] Huang T, Lu Z, Wang Z, et al. Targeting adipocyte ESRRA promotes osteogenesis and vascular formation in adipocyte-rich bone marrow[J]. Nat Commun, 2024, 15(1): 3769.

[23] [23] Gasparrini M, Rivas D, Elbaz A, et al. Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice[J]. Exp Gerontol, 2009, 44(9): 613-618.

[24] [24] Xie L, Cheng Y, Hu B, et al. PCLAF induces bone marrow adipocyte senescence and contributes to skeletal aging[J]. Bone Res, 2024, 12(1): 38.

[25] [25] Naot D, Musson DS, Cornish J. The activity of adiponectin in bone[J]. Calcif Tissue Int, 2016, 100(5): 486-499.

[26] [26] Fazeli PK, Bredella MA, Pachon-Pea G, et al. The dynamics of human bone marrow adipose tissue in response to feeding and fasting[J]. JCI Insight, 2021, 6(12): e138636.

[27] [27] Zhong L, Lu J, Fang J, et al. Csf1 from marrow adipogenic precursors is required for osteoclast formation and hematopoiesis in bone[J]. Elife, 2023, 12: e82112.

[28] [28] Yu W, Zhong L, Yao L, et al. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss[J]. J Clin Invest, 2021, 131(2): e140214.

[29] [29] Veldhuis-Vlug AG, Rosen CJ. Clinical implications of bone marrow adiposity[J]. J Intern Med, 2018, 283(2): 121-139.

[30] [30] Hu Y, Li X, Zhi X, et al. RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss[J]. EMBO Rep, 2021, 22(7): e52481.

[31] [31] Boroumand P, Prescott DC, Mukherjee T, et al. Bone marrow adipocytes drive the development of tissue invasive Ly6C high monocytes during obesity[J]. Elife, 2022, 11: e65553.

[32] [32] Hardaway AL, Herroon MK, Rajagurubandara E, et al. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer[J]. Clin Exp Metastasis, 2015, 32(4): 353-368.

[33] [33] Liu X, Gu Y, Kumar S, et al. Oxylipin-PPAR-initiated adipocyte senescence propagates secondary senescence in the bone marrow[J]. Cell Metab, 2023, 35(4): 667-684.e6.

[35] [35] Zhong L, Yao L, Tower RJ, et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment[J]. Elife, 2020, 9: e54695.

[36] [36] Pachn-Pea G, Bredella MA. Bone marrow adipose tissue in metabolic health[J]. Trends Endocrinol Metab, 2022, 33(6): 401-408.

[37] [37] Daniilopoulou I, Vlachou E, Lambrou GI, et al. The impact of GLP1 agonists on bone metabolism: asystematic review[J]. Medicina (Kaunas), 2022, 58(2): 224.

[38] [38] Hammoud R, Drucker DJ. Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1[J]. Nat Rev Endocrinol, 2022, 19(4): 201-216.

[39] [39] Aaseth JO, Alexander J. Postoperative osteoporosis in subjects with morbid obesity undergoing bariatric surgery with gastric bypass or sleeve gastrectomy[J]. Nutrients, 2023, 15(6): 1302.

[40] [40] Bachmann KN, Schorr M, Bruno AG, et al. Vertebral volumetric bone density and strength are impaired in women with low-weight and atypical anorexia nervosa[J]. J Clin Endocrinol Metab, 2017, 102(1): 57-68.